CPT code 90589 denotes a live, attenuated chikungunya virus vaccine administered via intramuscular injection. This code identifies the vaccine product itself and is relevant nationally as chikungunya prevention becomes a higher priority for public health programs and outpatient immunization services. Use of this code enables consistent reporting for coverage decisions, inventory tracking, and aggregate vaccine uptake assessments.

Key payers typically relevant for coverage and claims processing include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find benchmarks and policy-oriented context around payer coverage patterns, coding and billing considerations for vaccine administration services, and clinical context for where and how this vaccine is typically delivered. The analysis outlines common modifiers and service line implications where available, and notes areas where input data was not provided.

This summary is intended for administrators, coding professionals, and payers seeking a concise reference to the clinical and billing identity of CPT code 90589, its role in outpatient vaccination workflows, and the payer landscape commonly involved in vaccine reimbursement discussions.